AffyImmune to Present CAR T Therapy AIC100 Data at AACR 2025 Conference AffyImmune Therapeutics will showcase its CAR T therapy AIC100 during the AACR 2025 conference, detailing clinical data for advanced thyroid cancer treatment.

AffyImmune to Present CAR T Therapy AIC100 Data at AACR 2025 Conference #United_States #Chicago #AffyImmune #CAR_T_Therapy #AIC100

AffyImmune Promotes Dr. Deyaa Adib to Chief Medical Officer AffyImmune Therapeutics has appointed Dr. Deyaa Adib as Chief Medical Officer. His extensive oncology experience aims to enhance clinical development strategies for cancer therapies.

AffyImmune Promotes Dr. Deyaa Adib to Chief Medical Officer #USA #AffyImmune #Deyaa_Adib #CAR_T_Therapy #Natick,_Massachusetts